RETINALGENIX TECHNOLOGIES INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
RETINALGENIX TECHNOLOGIES INC. (RTGN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $2.11 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-04-15
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2024-03-31 was $1.17.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $2.11.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $1.17, a 108.93% increase from fiscal 2022.
- RETINALGENIX TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $0.56.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.11 10-K · filed 2026-04-15 | |||
| 2025-09-30 | $2.11 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | $2.11 10-Q/A · filed 2025-08-20 | |||
| 2024-12-31 | $2.13 10-Q · filed 2025-05-15 | |||
| 2024-09-30 | $1.17 10-Q · filed 2024-11-18 | |||
| 2024-06-30 | $1.17 10-Q · filed 2024-08-19 | |||
| 2024-03-31 | $1.17 10-Q · filed 2024-05-20 | |||
| 2023-12-31 | $1.17 10-K · filed 2024-04-01 | |||
| 2023-09-30 | $1.17 10-Q · filed 2023-11-14 | |||
| 2022-12-31 | $0.56 10-K · filed 2024-04-01 |